Citrulline supplementation attenuates the development of non-alcoholic steatohepatitis in female mice through mechanisms involving intestinal arginase

• Published in: Redox biology Vol. 41; p. 101879
• Main Authors: Rajcic, Dragana, Baumann, Anja, Hernández-Arriaga, Angélica, Brandt, Annette, Nier, Anika, Jin, Cheng Jun, Sánchez, Victor, Jung, Finn, Camarinha-Silva, Amélia, Bergheim, Ina
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01-05-2021; Elsevier
• Subjects: Arginase; Bacterial endotoxin; Hepatic inflammation; Intestinal permeability; Research Paper; NO; NAS; FFC; NAFLD; TNFα; C; E; F; GTT; Intestinal permeability; Arginase; ALT; Hepatic inflammation; AUC; 4-HNE; Gpr43; iNOS; Gpr41; Bacterial endotoxin; NOHA; ARG2; AST; L-Cit; NASH; Myd88; ZO-1; 3-NT; SEM; Tlr4; PCR
• ISSN: 2213-2317; 2213-2317
• DOI: 10.1016/j.redox.2021.101879

Non-alcoholic fatty liver disease (NAFLD) is by now the most prevalent liver disease worldwide. The non-proteogenic amino acid l-citrulline (L-Cit) has been shown to protect mice from the development of NAFLD. Here, we aimed to further assess if L-Cit also attenuates the progression of a pre-existing diet-induced NAFLD and to determine molecular mechanisms involved. Female C57BL/6J mice were either fed a liquid fat-, fructose- and cholesterol-rich diet (FFC) or control diet (C) for 8 weeks to induce early stages of NASH followed by 5 more weeks with either FFC-feeding +/- 2.5 g L-Cit/kg bw or C-feeding. In addition, female C57BL/6J mice were either pair-fed a FFC +/- 2.5 g L-Cit/kg bw +/- 0.01 g/kg bw i.p. N(ω)-hydroxy-nor-l-arginine (NOHA) or C diet for 8 weeks.
The protective effects of supplementing L-Cit on the progression of a pre-existing NAFLD were associated with an attenuation of 1) the increased translocation of bacterial endotoxin and 2) the loss of tight junction proteins as well as 3) arginase activity in small intestinal tissue, while no marked changes in intestinal microbiota composition were prevalent in small intestine. Treatment of mice with the arginase inhibitor NOHA abolished the protective effects of L-Cit on diet-induced NAFLD. Our results suggest that the protective effects of L-Cit on the development and progression of NAFLD are related to alterations of intestinal arginase activity and intestinal permeability.
[Display omitted]
•l-citrulline diminished progression of non-alcoholic fatty liver disease (NAFLD).•l-citrulline protects from fructose-induced small intestinal barrier dysfunction.•NASH development is associated with a loss of arginase activity in small intestine.•l-citrulline improves intestinal arginase activity in diet-induced NAFLD.•Arginase inhibitor attenuates effects of l-citrulline on NAFLD development.